News in the Life Sciences Industry

- Ortho's new SARS-CoV-2 antigen test offers 98.9% concordance[i] to real-time PCR tests, making it a viable alternative suitable for mass-scale testing

HONG KONG, Nov. 2, 2020 /PRNewswire/ -- On 29 October 2020, Ping An Doctor Home , Ping An Good Doctor's (stock code: 1833.HK) sub-brand, launched an industry first, "Online Comprehensive Medical Care", boasting medical accountability and medicine quality as its pillar services, and covering seven... Read more ››

First complete dataset in the IL-23p19 class demonstrates ILUMETRI(®)? (tildrakizumab) long term efficacy and safety through 5 years in Patients with Moderate to Severe Psoriasis

BRUSSELS, Oct. 31, 2020 /PRNewswire/ -- UCB, a global biopharmaceutical company, today announced the detailed results of the head-to-head Phase 3 BE SURE study, which demonstrated that patients treated with investigational IL-17A and IL-17F inhibitor bimekizumab achieved superior skin clearance,... Read more ››

SHANGHAI, Oct. 30, 2020 /PRNewswire/ -- The third China International Import Expo (CIIE) is entering the final stage of preparations as a huge road paving machine by German company Wirtgen Group became the first exhibit to arrive at the National Exhibition and Convention Center (Shanghai), the... Read more ››

ABBOTT PARK, Ill., Oct. 30, 2020 /PRNewswire/ -- Abbott (NYSE: ABT), a global healthcare leader focused on creating life-changing technologies that help people lead fuller and healthier lives, has received the 2020 Prix Galien USA Award for Best Medical Technology for its MitraClip(TM) System,... Read more ››

HAMBURG, Germany, Oct. 30, 2020 /PRNewswire/ -- BioAgilytix is thrilled to announce the addition of a new diagnostics tool to their growing list of cutting-edge bioanalysis instruments.

SHENZHEN, China, Oct. 29, 2020 /PRNewswire/ -- With the return from summer break, the continuation of COVID-Exit is much more prepared and planned, and elective surgery momentum has resumed. For physicians, safeguarding both patients, as well as themselves, is by far still the priority, especially... Read more ››

BRUSSELS, Oct. 29, 2020 /PRNewswire/ -- UCB, a global biopharmaceutical company, today announced that new data on the investigational IL-17A and IL-17F inhibitor, bimekizumab, and TNF inhibitor, CIMZIA(® )(certolizumab pegol), in the management of moderate-to-severe plaque psoriasis are being... Read more ››

HONG KONG and SHANGHAI, Oct. 29, 2020 /PRNewswire/ -- Ping An Insurance (Group) Company of China, Ltd. (hereafter "Ping An" or the "Group", HKEX: 02318; SSE: 601318) announced that Ping An's AskBob Doctor has demonstrated that its artificial intelligence (AI) capabilities in cardiovascular disease... Read more ››

Shelf-stable, ready-to-use testing plates compatible with COVID-19 testing labs